New SEC Form D filing

Nanopath Inc, 2026-11-13

A new SEC Form D private-offering notice from Cambridge, MA, a $36,760,740 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Nanopath Inc site↗ Verified via SEC Form D

Point-of-care molecular diagnostics company developing a rapid, amplification-free test for women's pelvic and gynecologic infections.

Filed 6 days agoFiled to raise $36,760,740First money in 2026-10-22Raised so far $29,891,706HQ (as filed) Cambridge, MASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified nanopath.com↗Named in the filing 4 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source